- Home
- FTFT vs SBFM Comparison
FTFT vs SBFM Comparison
Compare FTFT & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- SBFM
- Stock Information
- Founded
- FTFT N/A
- SBFM 2006
- Country
- FTFT United States
- SBFM United States
- Employees
- FTFT N/A
- SBFM N/A
- Industry
- FTFT Business Services
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- FTFT Consumer Discretionary
- SBFM Health Care
- Exchange
- FTFT Nasdaq
- SBFM Nasdaq
- Market Cap
- FTFT 6.2M
- SBFM 6.3M
- IPO Year
- FTFT N/A
- SBFM N/A
- Fundamental
- Price
- FTFT $0.19
- SBFM $1.91
- Analyst Decision
- FTFT
- SBFM Strong Buy
- Analyst Count
- FTFT 0
- SBFM 1
- Target Price
- FTFT N/A
- SBFM $15.00
- AVG Volume (30 Days)
- FTFT 11.9M
- SBFM 48.0K
- Earning Date
- FTFT 04-15-2025
- SBFM 03-27-2025
- Dividend Yield
- FTFT N/A
- SBFM N/A
- EPS Growth
- FTFT N/A
- SBFM N/A
- EPS
- FTFT N/A
- SBFM N/A
- Revenue
- FTFT $18,543,659.00
- SBFM $32,959,491.00
- Revenue This Year
- FTFT N/A
- SBFM $59.94
- Revenue Next Year
- FTFT N/A
- SBFM $164.69
- P/E Ratio
- FTFT N/A
- SBFM N/A
- Revenue Growth
- FTFT N/A
- SBFM 61.94
- 52 Week Low
- FTFT $0.18
- SBFM $1.90
- 52 Week High
- FTFT $1.21
- SBFM $266.00
- Technical
- Relative Strength Index (RSI)
- FTFT 34.34
- SBFM 28.63
- Support Level
- FTFT $0.20
- SBFM $2.02
- Resistance Level
- FTFT $0.25
- SBFM $2.49
- Average True Range (ATR)
- FTFT 0.04
- SBFM 0.18
- MACD
- FTFT -0.00
- SBFM -0.02
- Stochastic Oscillator
- FTFT 1.23
- SBFM 1.70
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.